Javier Tejedor Tejada-rekin lankidetzan egindako argitalpenak (6)

2021

  1. De-novo nonalcoholic fatty liver disease at 5 years after liver transplantation: prevalence and predictive factors

    European Journal of Gastroenterology and Hepatology, Vol. 33, Núm. 3, pp. 399-406

  2. Long-term clinical outcome and survival predictors in patients with cirrhosis after 10-mm-covered transjugular intrahepatic portosystemic shunt

    Gastroenterologia y Hepatologia, Vol. 44, Núm. 9, pp. 620-627

2020

  1. Immunosuppressive Treatment With mTOR Inhibitors for Malignancies After Liver Transplantation: Long-Term Survival Retrospective Analysis

    Transplantation Proceedings, Vol. 52, Núm. 5, pp. 1507-1510

  2. Utility of Ethyl-Glucuronide for Evaluation of Abstinence in Patients Presenting for Liver Transplantation

    Transplantation Proceedings, Vol. 52, Núm. 5, pp. 1450-1452

2019

  1. Efficacy of Direct-acting Antivirals to Improve Clinical Condition, Fibrosis, and Liver Function in Liver Transplant Recipients Infected by Hepatitis C

    Transplantation Proceedings, Vol. 51, Núm. 1, pp. 74-76

  2. Utility of Oral Anticoagulants as Prophylaxis of Recurrent Portal Thrombosis after Liver Transplantation

    Transplantation Proceedings, Vol. 51, Núm. 1, pp. 83-86